|  |
| |
| Figure 2. Diagram representing UHMK1 protein and the posttranslational modifications. UHMK1 is characterized by an N-terminal kinase core of 282 aminoacids, represented in green and a C-terminal UHM of 100 aminoacids, represented in violet. All residues described to be phosphorylated or ubiquitinated in large scale proteomic studies are depicted. Source: Phosphoproteomic databases PhosphoSitePlus (http://www.phosphosite.org). UHM: U2AF homology motif (modified from Archangelo, et al. 2013). |
| |
Description | UHMK1 is a serine/threonine kinase with calculated molecular weight of 46.5 kDa and a theoretical pI of 5.59 (PhosphoSite Plus). The primary sequence of the protein is characterized by an N-terminal kinase core (282 aminoacids) and the C-terminal U2AF homology motif (UHM), responsible for establishing protein interactions with UHM-ligand motifs (ULM), particularly present among splicing factors (Kielkopf et al., 2004; Manceau et al., 2006). UHMK1 phosphorylates preferentially proline directed serine residues on its target proteins (Maucuer et al., 2000). The lysine 54 within the N-terminal region is essential for its kinase activity and autophosphorylation activity has been observed (Boehm et al., 2002; Maucuer et al., 1997). A variety of large scale proteomic studies identified two types of posttranslational modifications within UHMK1, namely lysine-ubiquitination (K190-ub, K282-ub, K383-ub and K387-ub) and phosphorylation (Y197-p, S283-p and S290-p) as indicated at the phosphoproteomic database PhosphoSitePlus (http://www.phosphosite.org) (Figure 2). |
Expression | UHMK1 is ubiquitously expressed throughout rat and human tissues, with enriched expression in the nervous system (Bieche et al., 2003; Caldwell et al., 1999; Maucuer et al., 1997). Uhmk1 mRNA is expressed during rat embryonic development and increases after birth and during the first month of brain development (Bieche et al., 2003). In the adult brain, in situ hybridization revealed remarkable expression in the substantia nigra and some sensorial and motor nuclei in the brain stem (Bieche et al., 2003). In the human brain, UHMK1 expression was detected in all regions examined, with highest levels in the deeper cortical layers. Strong expression was observed in dentate gyrus, CA1, CA3 and CA4 regions of the hippocampus, in Purkinje cells and granule cell layer of the cerebellum. No expression was detected in the white matter (Bristow et al., 2009). In the hematopoietic compartment, high levels of UHMK1 transcripts were observed in differentiated lymphocytes (CD4+, CD8+ and CD19+) compared to the progenitor enriched subpopulation (CD34+) or leukemia cell lines. UHMK1 expression was upregulated in megakaryocytic-, monocytic- and granulocytic-induced differentiation of leukemia cell lines and in erythrocytic-induced differentiation of primary CD34+ cells (Barbutti et al., 2017). Levels of UHMK1 protein are induced by mitogens. In serum starved cells, UHMK1 expression was reduced in contrast to serum stimulated cells (Boehm et al., 2002; Crook et al., 2008; Petrovic et al., 2008). UHMK1 expression increased after quiescent peripheral blood lymphocytes (PBLs) were induced to proliferate upon mitogen activation (Barbutti et al., 2017). Moreover, the amount of UHMK1 protein varies throughout the cell cycle. In synchronized cells, UHMK1 accumulates in G1 phase and decreases during S phase of the cell cycle (Archangelo et al., 2013). Little is known about the transcriptional regulation of UHMK1, which was described as direct target of the transcription factors GABP (Crook et al., 2008) and FOXM1 (Petrovic et al., 2008). The core promoter region of UHMK1 was described within -141 to -41 base pairs upstream of the transcription start site and has no consensus sequences for TATA or CCAAT boxes. Instead, it has GC-box and 3 Ets-binding sites (EBS-1, EBS-2 and EBS-3), which are essential for the promoter activity, in vitro. The regions spanning EBS-1 and EBS-2 (-103/-73 bp), and EBS-3 (-52/-42 bp) bind GABP in response to serum, leading to UHMK1 expression, cell migration and cell cycle progression of VSCM cells (Crook et al., 2008). FoxM1 binds an internal regulatory region within UHMK1 and transactivates its expression in vitro. FoxM1 appears to be essential for serum-dependent activation of UHMK1 mRNA expression, as assessed in FoxM1-/- MEF cells. It was suggested that FoxM1-induced UHMK1 expression is required for UHMK1-mediated phosphorylation and consequently degradation of CDKN1B (p27Kip1) (Petrovic et al., 2008). Furthermore, UHMK1 was described as transcriptional target of the WD repeat domain 5 (WDR5), a core component of the KMT2A (MLL) / SETD1A complex, known for its methyltransferase activity on H3 lysine 4 (H3K4). The H3K4me3 epigenetic modification correlates with gene activation, thus it is suggested that WDR5-mediated H3K4me3 at UHMK1 locus promotes its expression (Chen et al., 2015). |
|  |
| |
| Figure 3. Subcellular localization of Uhmk1. Confocal image of HeLa cells transiently transfected with plasmid expressing ha-tagged Uhmk1 (pECE-HA-Kis; Manceau et al, 2008). Ectopic Uhmk1 localizes mainly to the nucleus and to a lesser extent to the cytoplasm. The anti-Kis 3B12 antibody (Manceau et al, 2012) and Phalloidin (Invitrogen A1238) were used to detected Uhmk1 and Actin, respectively. 63x objective, zoom 2,5 x. Personal data. |
| |
Localisation | The UHMK1 protein localizes mainly to the nucleus and to a lesser extent to the cytoplasm (Boehm et al., 2002; Maucuer et al., 1997) (Figure 3). Shuttling between nucleus and cytoplasm has been described for the GFP-fused protein by fluorescence recovery after photobleaching (FRAP) (Francone et al., 2010). The kinase domain is essential for the protein nuclear localization, since deletion mutants of this domain, particularly the residues 1-211, extinguished Uhmk1 signal in immunofluorescence analysis (Manceau et al., 2008). Overexpressed ha-tagged Uhmk1 localized to the RNA granules of axon and dendrites of cortical neurons (Cambray et al., 2009). Also, a nucleolar enriched localization was observed when ha-tagged Uhmk1 was co-expressed with its GFP-fused interacting partner PIMREG (Archangelo et al., 2013). |
|  |
| |
| Figure 4. Potential functions of UHMK1. 1- UHMK1 interacts with and phosphorylates the splicing factors SF1 and SF3B1. 2- UHMK1 counteracts the inhibitory effect of p27Kip1 on cell cycle. Upon mitogenic activation, UHMK1 is upregulated and phosphorylates p27Kip1, which is exported from the nucleus and targeted for degradation by the proteasome. 3- UHMK1 impairs cell migration through negatively regulating the microtubule destabilizing protein Stathmin (STMN). UHMK1-mediated phosphorylation of STMN on S38 targets the protein for degradation. 4- UHMK1 regulates the secretory pathway in neurons and endocrine cells through its interaction with the peptidylglycine α-amidating mono-oxigenase (PAM). 5- UHMK1 interacts with components of neuronal RNA granules, such as KIF3A, NonO and eEF1A. It also associates with RNP-transported mRNAs and stimulates translation driven by the β-actin 3' UTR. 6- UHMK1 interacts with and phosphorylates the proliferation marker PIMREG, suggesting a potential role in regulating proliferation. Black arrow: represents the mitogen-dependent activation of UHMK1. Grey arrows: indicate the UHMK1-mediated phosphorylation of target proteins. Grey dotted arrows: represent the fate of the UHMK1 phosphorylated proteins targeted for degradation. P: phosphorylation; Ub: ubiquitination. Illustration was drawn using Servier Medical Art. |
| |
Function | UHMK1 was described to interact with a range of proteins, shedding light on different functions of this protein in diverse cellular processes (Figure 4). UHMK1 is the only kinase that possesses the N-terminal kinase core juxtaposed to a C-terminal U2AF homology motif (UHM) (Maucuer et al., 1997). Through the UHM motif, UHMK1 interacts with the splicing factors SF1 and SF3B1 (Manceau et al., 2008). Upon interaction, UHMK1 phosphorylates SF1, which enhances SF1 specific binding to U2AF65 and reduces the SF1-U2AF65 binding to the 3' splice site RNA (Chatrikhi et al., 2016; Manceau et al., 2006). In addition, UHMK1 expression is necessary for normal phosphorylation of SF1 in vivo (Manceau et al., 2012). The fact that UHMK1 interacts with and regulates splicing factors suggests that UHMK1 might be involved in RNA metabolism. Since UHMK1 is highly expressed in neurons, it is expected to exerts important functions in the nervous system. It was demonstrated an abnormal phosphorylation of SF1 in brain extracts of neonate Uhmk1-/- mice. Also, Uhmk1 deletion resulted in increased ratio of pre-mRNA relative to mRNA, and consequently down-regulation of brain specific genes, like cys-loop ligand-gated ion channels and metabolic enzymes. Although adult Uhmk1-/- mice did not present an obvious phenotype, animal behavior was affected. The Uhmk1-/- mice displayed locomotor hyperactivity, reduced fear conditioning and learning capacities from aversive stimuli (Manceau et al., 2012). The murine Uhmk1 was described to interact with known components of neuronal RNA granules, such as KIF3A, NONO and EEF1A1. The protein colocalizes with KIF3A kinesin in neurites and is required for neuritic outgrowth in cortical mouse neurons. Furthermore, Uhmk1 associates with RNP-transported mRNAs and stimulate translation driven by the β-actin 3' UTR, suggesting that Uhmk1 contributes to modulate translation in RNA-transporting granules as a result of local signals (Cambray et al., 2009). Still, comparison of primary cultures derived from Uhmk1-/- mice did not reveal a significant difference in neuritic arborization of cortical neurons (Manceau et al., 2012). Furthermore, a study investigating Uhmk1 action on hippocampal synaptic plasticity in mice, showed that Uhmk1 knockdown impaired spine development, altered actin dynamics, and reduced postsynaptic responsiveness. Moreover, Uhmk1 depletion resulted in decrease of the postsynaptic scaffolding protein PSD-95 and of AMPA receptor subunits. Thus Uhmk1 enhances translation of AMPA receptors and stimulates dendritic spine remodeling (Pedraza et al., 2014). Another described function of UHMK1 involves the regulation of secretory pathway in neurons and endocrine cells through its interaction with peptidylglycine α-amidating mono-oxigenase (PAM) (Alam et al., 1996). PAM cytosolic domain (CD) phosphorylation by UHMK1 (Ser-949) is required for the correct routing of this protein and consequently for its ability to affect trafficking in the regulated secretion pathway (Alam et al., 2001; Caldwell et al., 1999). Lately, it was described an intramembrane proteolysis pathway for PAM, generating a soluble fragment of the cytosolic domain (sf-CD), which accumulates in the nucleus in a phosphorylation-dependent manner, modulating the expression of genes involved in the secretory pathway. UHMK1 phosphorylates sf-CD, diminishing its localization in the nucleus and negatively regulating the expression of a subset of genes (Francone et al., 2010; Rajagopal et al., 2010). An extensively documented function of UHMK1 is its ability to positively regulate cell cycle progression through phosphorylation and inhibition of the cyclin dependent kinase inhibitor (CDKI) p27Kip1. Upon mitogenic activation, UHMK1 expression is upregulated and phosphorylates p27Kip1 on serine 10 (Ser10). As a consequence, p27Kip1 is exported from nucleus to cytoplasm, where it is targeted to the proteasome and degraded, and has no longer inhibitory effect on cell cycle. Thus, UHMK1 promotes cell cycle re-entry by inactivating p27Kip1 following growth factor stimulation (Boehm et al., 2002). Another important target of UHMK1 is the microtubule-destabilizing protein, Stathmin (Maucuer et al., 1995). UHMK1 interacts with and phosphorylates Stathmin on serine 38 (Ser38), targeting this protein to proteasome. Through negative regulation of Stathmin, UHMK1 alter microtubule dynamics and consequently impairs cell migration (Langenickel et al., 2008). UHMK1 expression is upregulated upon hematopoietic cell differentiation, thus a possible role of UHMK1 in cell differentiation was proposed (Barbutti et al., 2017). This idea was supported by the fact that UHMK1 mRNA is highly expressed in the mature brain and in terminally differentiated neural cells (Bieche et al., 2003) as well as during osteoclasts differentiation (Choi et al., 2016). The human UHMK1 shares high homology with a number of species as depicted in Table 1. PIMREG (previously known as FAM64A; CATS) is a proliferation marker shown to interact with UHMK1. The fact that UHMK1 interacts with and phosphorylates PIMREG suggests that UHMK1 regulates PIMREG function and/or localization. Nevertheless, the functional implication of this interaction remains elusive (Archangelo et al., 2013). |
Homology | The human UHMK1 shares high homology with a number of species as depicted in Table 1. The human UHMK1 shares high homology with a number of species as depicted in Table 1. Table 1. Homology between the human UHMK1 and other species Homo sapiens UHMK1 | Symbol | Protein (% Identity) | DNA(% Identity) | vs. P. troglodytes vs. M. mulatta | UHMK1 UHMK1 | 99.8 (XP_001174268) 99.8 (NP_001253697) | 99.7 (XM_001174268) 99.0 (NM_001266768) | vs. C. lupus | UHMK1 | 99.8 (XP_536143) | 95.8 (XM_536143) | vs. B. taurus | UHMK1 | 99.8 (NP_001192514) | 95.9 (NM_001205585) | vs. M. musculus | Uhmk1 | 99.3 (NP_034763) | 93.0 (NM_010633) | vs. R. norvegicus | Uhmk1 | 99.3 (NP_058989) | 92.6 (NM_017293) | vs. G. gallus | UHMK1 | 88.2 (XP_015145890) | 81.6 (XM_015290404) | vs. D. rerio | uhmk1 | 73.6 (NP_001070127) | 69.4 (NM_001076659) |
(Source: http://www.ncbi.nlm.nih.gov/homologene/) |
Signaling mediated by the cytosolic domain of peptidylglycine alpha-amidating monooxygenase |
Alam MR, Steveson TC, Johnson RC, Bäck N, Abraham B, Mains RE, Eipper BA |
Mol Biol Cell 2001 Mar;12(3):629-44 |
PMID 11251076 |
|
The CATS (FAM64A) protein is a substrate of the Kinase Interacting Stathmin (KIS) |
Archangelo LF, Greif PA, Maucuer A, Manceau V, Koneru N, Bigarella CL, Niemann F, dos Santos MT, Kobarg J, Bohlander SK, Saad ST |
Biochim Biophys Acta 2013 May;1833(5):1269-79 |
PMID 23419774 |
|
The U2AF homology motif kinase 1 (UHMK1) is upregulated upon hematopoietic cell differentiation. |
Barbutti I, Machado-Neto J, Arfelli V, Campos P, Traina F, Saad S, and Archangelo L. |
2017. DOI: 10.1101/187385. |
|
Case-control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population |
Betcheva ET, Mushiroda T, Takahashi A, Kubo M, Karachanak SK, Zaharieva IT, Vazharova RV, Dimova II, Milanova VK, Tolev T, Kirov G, Owen MJ, O'Donovan MC, Kamatani N, Nakamura Y, Toncheva DI |
J Hum Genet 2009 Feb;54(2):98-107 |
PMID 19158809 |
|
Quantitative RT-PCR reveals a ubiquitous but preferentially neural expression of the KIS gene in rat and human |
Bièche I, Manceau V, Curmi PA, Laurendeau I, Lachkar S, Leroy K, Vidaud D, Sobel A, Maucuer A |
Brain Res Mol Brain Res 2003 May 26;114(1):55-64 |
PMID 12782393 |
|
A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression |
Boehm M, Yoshimoto T, Crook MF, Nallamshetty S, True A, Nabel GJ, Nabel EG |
EMBO J 2002 Jul 1;21(13):3390-401 |
PMID 12093740 |
|
Novel genetic causes for cerebral visual impairment |
Bosch DG, Boonstra FN, de Leeuw N, Pfundt R, Nillesen WM, de Ligt J, Gilissen C, Jhangiani S, Lupski JR, Cremers FP, de Vries BB |
Eur J Hum Genet 2016 May;24(5):660-5 |
PMID 26350515 |
|
Expression of kinase interacting with stathmin (KIS, UHMK1) in human brain and lymphoblasts: Effects of schizophrenia and genotype |
Bristow GC, Lane TA, Walker M, Chen L, Sei Y, Hyde TM, Kleinman JE, Harrison PJ, Eastwood SL |
Brain Res 2009 Dec 8;1301:197-206 |
PMID 19747464 |
|
The novel kinase peptidylglycine alpha-amidating monooxygenase cytosolic interactor protein 2 interacts with the cytosolic routing determinants of the peptide processing enzyme peptidylglycine alpha-amidating monooxygenase |
Caldwell BD, Darlington DN, Penzes P, Johnson RC, Eipper BA, Mains RE |
J Biol Chem 1999 Dec 3;274(49):34646-56 |
PMID 10574929 |
|
Protein kinase KIS localizes to RNA granules and enhances local translation |
Cambray S, Pedraza N, Rafel M, Garí E, Aldea M, Gallego C |
Mol Cell Biol 2009 Feb;29(3):726-35 |
PMID 19015237 |
|
SF1 Phosphorylation Enhances Specific Binding to U2AF(65) and Reduces Binding to 3'-Splice-Site RNA |
Chatrikhi R, Wang W, Gupta A, Loerch S, Maucuer A, Kielkopf CL |
Biophys J 2016 Dec 20;111(12):2570-2586 |
PMID 28002734 |
|
Upregulated WDR5 promotes proliferation, self-renewal and chemoresistance in bladder cancer via mediating H3K4 trimethylation |
Chen X, Xie W, Gu P, Cai Q, Wang B, Xie Y, Dong W, He W, Zhong G, Lin T, Huang J |
Sci Rep 2015 Feb 6;5:8293 |
PMID 25656485 |
|
Genome-wide association study in East Asians suggests UHMK1 as a novel bone mineral density susceptibility gene |
Choi HJ, Park H, Zhang L, Kim JH, Kim YA, Yang JY, Pei YF, Tian Q, Shen H, Hwang JY, Deng HW, Cho NH, Shin CS |
Bone 2016 Oct;91:113-21 |
PMID 27424934 |
|
GA-binding protein regulates KIS gene expression, cell migration, and cell cycle progression |
Crook MF, Olive M, Xue HH, Langenickel TH, Boehm M, Leonard WJ, Nabel EG |
FASEB J 2008 Jan;22(1):225-35 |
PMID 17726090 |
|
Genetic and molecular exploration of UHMK1 in schizophrenic patients |
Dumaine A, Maucuer A, Barbet A, Manceau V, Deshommes J, Méary A, Szöke A, Schürhoff F, Llorca PM, Lancon C, Leboyer M, Jamain S |
Psychiatr Genet 2011 Dec;21(6):315-8 |
PMID 21399567 |
|
Signaling from the secretory granule to the nucleus: Uhmk1 and PAM |
Francone VP, Ifrim MF, Rajagopal C, Leddy CJ, Wang Y, Carson JH, Mains RE, Eipper BA |
Mol Endocrinol 2010 Aug;24(8):1543-58 |
PMID 20573687 |
|
U2AF homology motifs: protein recognition in the RRM world |
Kielkopf CL, Lücke S, Green MR |
Genes Dev 2004 Jul 1;18(13):1513-26 |
PMID 15231733 |
|
KIS protects against adverse vascular remodeling by opposing stathmin-mediated VSMC migration in mice |
Langenickel TH, Olive M, Boehm M, San H, Crook MF, Nabel EG |
J Clin Invest 2008 Dec;118(12):3848-59 |
PMID 19033656 |
|
HER2-targeting antibodies modulate the cyclin-dependent kinase inhibitor p27Kip1 via multiple signaling pathways |
Le XF, Pruefer F, Bast RC Jr |
Cell Cycle 2005 Jan;4(1):87-95 |
PMID 15611642 |
|
PI 3-kinase/Rac1 and ERK1/2 regulate FGF-2-mediated cell proliferation through phosphorylation of p27 at Ser10 by KIS and at Thr187 by Cdc25A/Cdk2 |
Lee JG, Kay EP |
Invest Ophthalmol Vis Sci 2011 Jan 21;52(1):417-26 |
PMID 20811053 |
|
Human corneal endothelial cells employ phosphorylation of p27(Kip1) at both Ser10 and Thr187 sites for FGF-2-mediated cell proliferation via PI 3-kinase |
Lee JG, Song JS, Smith RE, Kay EP |
Invest Ophthalmol Vis Sci 2011 Oct 17;52(11):8216-23 |
PMID 21948550 |
|
The protein kinase KIS impacts gene expression during development and fear conditioning in adult mice |
Manceau V, Kremmer E, Nabel EG, Maucuer A |
PLoS One 2012;7(8):e43946 |
PMID 22937132 |
|
Major phosphorylation of SF1 on adjacent Ser-Pro motifs enhances interaction with U2AF65 |
Manceau V, Swenson M, Le Caer JP, Sobel A, Kielkopf CL, Maucuer A |
FEBS J 2006 Feb;273(3):577-87 |
PMID 16420481 |
|
Stathmin interaction with a putative kinase and coiled-coil-forming protein domains |
Maucuer A, Camonis JH, Sobel A |
Proc Natl Acad Sci U S A 1995 Apr 11;92(8):3100-4 |
PMID 7724523 |
|
Specific Ser-Pro phosphorylation by the RNA-recognition motif containing kinase KIS |
Maucuer A, Le Caer JP, Manceau V, Sobel A |
Eur J Biochem 2000 Jul;267(14):4456-64 |
PMID 10880969 |
|
KIS is a protein kinase with an RNA recognition motif |
Maucuer A, Ozon S, Manceau V, Gavet O, Lawler S, Curmi P, Sobel A |
J Biol Chem 1997 Sep 12;272(37):23151-6 |
PMID 9287318 |
|
KIS, a kinase associated with microtubule regulators, enhances translation of AMPA receptors and stimulates dendritic spine remodeling |
Pedraza N, Ortiz R, Cornadó A, Llobet A, Aldea M, Gallego C |
J Neurosci 2014 Oct 15;34(42):13988-97 |
PMID 25319695 |
|
FoxM1 regulates growth factor-induced expression of kinase-interacting stathmin (KIS) to promote cell cycle progression |
Petrovic V, Costa RH, Lau LF, Raychaudhuri P, Tyner AL |
J Biol Chem 2008 Jan 4;283(1):453-60 |
PMID 17984092 |
|
Confirmation of the genetic association between the U2AF homology motif (UHM) kinase 1 (UHMK1) gene and schizophrenia on chromosome 1q23 |
Puri V, McQuillin A, Datta S, Choudhury K, Pimm J, Thirumalai S, Krasucki R, Lawrence J, Quested D, Bass N, Crombie C, Fraser G, Walker N, Moorey H, Ray MK, Sule A, Curtis D, St Clair D, Gurling H |
3 Eur J Hum Genet |
PMID 18414510 |
|
Secretion stimulates intramembrane proteolysis of a secretory granule membrane enzyme |
Rajagopal C, Stone KL, Mains RE, Eipper BA |
J Biol Chem 2010 Nov 5;285(45):34632-42 |
PMID 20817724 |
|
Silencing kinase-interacting stathmin gene enhances erlotinib sensitivity by inhibiting Ser p27 phosphorylation in epidermal growth factor receptor-expressing breast cancer |
Zhang D, Tari AM, Akar U, Arun BK, LaFortune TA, Nieves-Alicea R, Hortobagyi GN, Ueno NT |
Mol Cancer Ther 2010 Nov;9(11):3090-9 |
PMID 21045138 |
|